FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2103261355> ?p ?o ?g. }

• W2103261355 endingPage "42" @default.
• W2103261355 startingPage "5239" @default.
• W2103261355 abstract "Inactivation of the p53 tumor suppressor gene usually involves somatic mutation or binding of viral oncoproteins to the p53 protein. However, several types of malignant and premalignant tissues harbor a genetically wild-type, but transcriptionally inactive, form of p53, often localized in the cytoplasm. Electrophilic prostaglandins (PGs) are known to sequester and inactivate p53 in the cytoplasm, an effect that is likely to occur when cyclooxygenase (COX)-2 levels become elevated during colon carcinogenesis. We determined the localization and expression of p53 in the presence of PGA(1) and celecoxib, a selective COX-2 inhibitor in human colon cell lines HCT-116 (wild-type p53) and HT-29 (mutant p53). In the absence of treatment, p53 protein accumulated preferentially in the nucleus in both cell lines. We observed that the total cellular levels of p53 protein increased with exposure time and concentration of PGA(1). By contrast, p21 protein levels remained unchanged as a function of time and concentration of PGA(1). In the presence of 20 micro M PGA(1), p53 accumulated preferentially in the cytosol. The nuclear:cytosol ratios of p53 were 31 and 2.1 in the controls and in the presence of PGA(1) in HCT-116 cells but were 22 and 4, respectively, in HT-29 cells. Treatment with 50 micro M celecoxib for 24 h did not significantly change p53 expression and localization. However, in the presence of 100 micro M celecoxib, p53 levels increased in the nucleus. The nuclear:cytosol ratios were then 31 (control) and 60 (100 micro M celecoxib) in HCT-116 cells and 22 (control) and 36 (100 micro M celecoxib) in HT-29 cells. These results indicate that electrophilic PGs cause wild-type p53 accumulation in the cytosol where it is inactive. Inhibition of COX-2 by celecoxib appears to alleviate this effect on p53 by reducing electrophilic PG synthesis. Thus, COX-2 inhibition of electrophilic PG formation appears to protect p53 tumor suppressor function." @default.
• W2103261355 created "2016-06-24" @default.
• W2103261355 creator A5009422422 @default.
• W2103261355 creator A5012274510 @default.
• W2103261355 creator A5019022652 @default.
• W2103261355 date "2003-09-01" @default.
• W2103261355 modified "2023-09-30" @default.
• W2103261355 title "Inhibition of COX-2 in colon cancer cell lines by celecoxib increases the nuclear localization of active p53." @default.
• W2103261355 cites W140965324 @default.
• W2103261355 cites W1498592938 @default.
• W2103261355 cites W1544157645 @default.
• W2103261355 cites W165254100 @default.
• W2103261355 cites W1868796410 @default.
• W2103261355 cites W1870025411 @default.
• W2103261355 cites W1906462579 @default.
• W2103261355 cites W1967132242 @default.
• W2103261355 cites W1987736530 @default.
• W2103261355 cites W1991106719 @default.
• W2103261355 cites W1997646834 @default.
• W2103261355 cites W2007935491 @default.
• W2103261355 cites W2008301561 @default.
• W2103261355 cites W2012053348 @default.
• W2103261355 cites W2014034874 @default.
• W2103261355 cites W2035032997 @default.
• W2103261355 cites W2043284283 @default.
• W2103261355 cites W2045074746 @default.
• W2103261355 cites W2045208826 @default.
• W2103261355 cites W2051686420 @default.
• W2103261355 cites W2060584880 @default.
• W2103261355 cites W2060810889 @default.
• W2103261355 cites W2070061120 @default.
• W2103261355 cites W2096652490 @default.
• W2103261355 cites W2105372476 @default.
• W2103261355 cites W2117580825 @default.
• W2103261355 cites W2119432641 @default.
• W2103261355 cites W2149233326 @default.
• W2103261355 cites W2156299289 @default.
• W2103261355 cites W2159973565 @default.
• W2103261355 cites W2161873970 @default.
• W2103261355 cites W2211971801 @default.
• W2103261355 cites W2291425780 @default.
• W2103261355 cites W2336215030 @default.
• W2103261355 cites W2413167357 @default.
• W2103261355 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14500353" @default.
• W2103261355 hasPublicationYear "2003" @default.
• W2103261355 type Work @default.
• W2103261355 sameAs 2103261355 @default.
• W2103261355 citedByCount "29" @default.
• W2103261355 countsByYear W21032613552012 @default.
• W2103261355 countsByYear W21032613552013 @default.
• W2103261355 countsByYear W21032613552014 @default.
• W2103261355 countsByYear W21032613552015 @default.
• W2103261355 countsByYear W21032613552016 @default.
• W2103261355 countsByYear W21032613552018 @default.
• W2103261355 countsByYear W21032613552019 @default.
• W2103261355 countsByYear W21032613552020 @default.
• W2103261355 crossrefType "journal-article" @default.
• W2103261355 hasAuthorship W2103261355A5009422422 @default.
• W2103261355 hasAuthorship W2103261355A5012274510 @default.
• W2103261355 hasAuthorship W2103261355A5019022652 @default.
• W2103261355 hasConcept C104317684 @default.
• W2103261355 hasConcept C143065580 @default.
• W2103261355 hasConcept C1491633281 @default.
• W2103261355 hasConcept C153911025 @default.
• W2103261355 hasConcept C181199279 @default.
• W2103261355 hasConcept C185592680 @default.
• W2103261355 hasConcept C190062978 @default.
• W2103261355 hasConcept C207583985 @default.
• W2103261355 hasConcept C2776467144 @default.
• W2103261355 hasConcept C2778264664 @default.
• W2103261355 hasConcept C29512474 @default.
• W2103261355 hasConcept C502942594 @default.
• W2103261355 hasConcept C54355233 @default.
• W2103261355 hasConcept C55493867 @default.
• W2103261355 hasConcept C555283112 @default.
• W2103261355 hasConcept C81885089 @default.
• W2103261355 hasConcept C86339819 @default.
• W2103261355 hasConcept C86803240 @default.
• W2103261355 hasConcept C98539663 @default.
• W2103261355 hasConceptScore W2103261355C104317684 @default.
• W2103261355 hasConceptScore W2103261355C143065580 @default.
• W2103261355 hasConceptScore W2103261355C1491633281 @default.
• W2103261355 hasConceptScore W2103261355C153911025 @default.
• W2103261355 hasConceptScore W2103261355C181199279 @default.
• W2103261355 hasConceptScore W2103261355C185592680 @default.
• W2103261355 hasConceptScore W2103261355C190062978 @default.
• W2103261355 hasConceptScore W2103261355C207583985 @default.
• W2103261355 hasConceptScore W2103261355C2776467144 @default.
• W2103261355 hasConceptScore W2103261355C2778264664 @default.
• W2103261355 hasConceptScore W2103261355C29512474 @default.
• W2103261355 hasConceptScore W2103261355C502942594 @default.
• W2103261355 hasConceptScore W2103261355C54355233 @default.
• W2103261355 hasConceptScore W2103261355C55493867 @default.
• W2103261355 hasConceptScore W2103261355C555283112 @default.
• W2103261355 hasConceptScore W2103261355C81885089 @default.
• W2103261355 hasConceptScore W2103261355C86339819 @default.
• W2103261355 hasConceptScore W2103261355C86803240 @default.
• W2103261355 hasConceptScore W2103261355C98539663 @default.

• next